Somryst is a prescription-only digital therapeutic app for chronic insomnia, delivering structured CBT-I programs on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Medical
Sentiment
3.2
5 reviews
Nemesis
CBT-i Coach
The App DNA
What makes this app unique?
Patients hire Somryst for clinically-validated behavioral modification that exceeds the efficacy of generic sleep hygiene apps, ensuring their progress is trackable by healthcare providers.
For Patients diagnosed with chronic insomnia requiring a structured, clinically-guided behavioral therapy program.
Key features
Structured cognitive behavioral therapy for insomnia focusing on habits, routines, and dysfunctional thoughts.
Tools for users to log sleep data and view insights for review by a healthcare provider.
Maintains program functionality and data access during periods of lost internet connectivity.
How much does it cost?
The app operates as a prescription digital therapeutic, requiring physician involvement rather than standard consumer subscription tiers.
Velocity
Maintenance developmentUX improvementsaccessibilityperformanceShow more...
The app has seen only two releases in the last 11 months, both occurring in June 2025. With a release cadence of approximately 0.04 releases per week, the development activity falls into the maintenance category. The latest release focused on accessibility, offline support, and notification improvements, but there has been no subsequent activity for nearly a year. The development trend is currently stagnant.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads mixed. Users appreciate sleep science methodology provides a structured approach to managing chronic insomnia symptoms.
How are ratings & reviews evolving?
What users say, by theme
- Sleep science methodology provides a structured approach to managing chronic insomnia symptoms
- Persistent session expiration and authentication failures disrupt the daily user experience post-update
4 of 4 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Somryst
How's the Medical market?
Somryst maintains a niche position as a prescription-only therapeutic, though its 3.2-star rating and minimal review count suggest limited market penetration compared to established public-sector alternatives.
Read the market outlookThe rivals identified
By US Department of Veterans Affairs (VA)
As the gold-standard public sector alternative, this app directly competes for the same clinical CBT-I user base by offering a comprehensive, evidence-based digital program.
- Massive user trust and credibility derived from its official US Department of Veterans Affairs backing
- Extensive, battle-tested feature set including advanced sleep diary tracking and robust health data integration
- Zero-cost barrier to entry provides a significant competitive advantage over paid or prescription-gated alternatives
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Somryst
Where is it heading?
The digital therapeutic market is consolidating around platforms that offer both clinical rigor and high-availability access, leaving Somryst exposed due to its current technical instability. Unless the team resolves the authentication and layout regressions, the app will continue to lose ground to more stable, user-friendly alternatives.
- Technical regressions in the latest update (forced logouts, UI layout errors) disrupt the daily therapeutic habit, which accelerates churn pressure.
- The lack of desktop parity complicates password management for mobile-first users, creating unnecessary friction that drives users toward more accessible competitors.
The SWOT
- Prescription-only model establishes clinical legitimacy
- Structured CBT-I curriculum drives behavioral change
- Desktop platform support reduces user friction
- Integration with telehealth platforms expands reach
Next best moves
Rebuild authentication flow because session expiration is the top complaint → stabilize daily active habit.
+ 1 more prioritized moveThe counter-intuitive read
The prescription-only model is not a barrier to entry but a liability…
Read the full takeFeature gaps
Desktop platform support (available in Sleepio 3.0 but missing here) +1
Since the last report: The app's competitive position has declined due to technical instability and UI regressions, forcing a pivot from growth-oriented telehealth integration to urgent maintenance.
Bottom line
Somryst provides a clinically-validated insomnia program, but technical instability in the latest version threatens user retention, so the team must prioritize authentication and layout fixes to ensure the therapeutic habit is not broken.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated